Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRSP compared with NTLA: revenue, margins and what each company keeps, and the suppliers and customers both name
CRSP
CRISPR Therapeutics AG
Change
Mkt cap
Revenue
Revenue
NTLA
Intellia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRSP
CRISPR Therapeutics AG
vs
NTLA
Intellia Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CRSP, solid
NTLA, dashed
CRSP
CRISPR Therapeutics AG
Change
50.08
▲
+3.13%
· post 50.00
Mkt cap
$4.9B
Revenue
$13M
Q3 FY26
Revenue
$4M
FY25
NTLA
Intellia Therapeutics, Inc.
Change
11.35
▲
+2.23%
· post 11.31
Closed
Nov 6 '26
Mkt cap
$1.6B
Revenue
$7M
Q3 FY26
Revenue
$68M
FY25
vs
Compare
Closed
Nov 6 '26
CRSP
CRISPR Therapeutics AG
vs
NTLA
Intellia Therapeutics, Inc.
50.08
▲
+3.13%
post 50.00
Price
11.35
▲
+2.23%
post 11.31
$4.9B
Mkt cap
$1.6B
Q3 FY26
$13M
Revenue
$7M
Q3 FY26
FY25
$4M
Revenue
$68M
FY25
Change
Change
CRSP
50.08
▲
+3.13%
vs
NTLA
11.35
▲
+2.23%
Closed
Nov 6 '26